TECOGEN INC. Reports Director and Officer Changes
Ticker: TGEN · Form: 8-K · Filed: Mar 7, 2024 · CIK: 1537435
| Field | Detail |
|---|---|
| Company | Tecogen Inc. (TGEN) |
| Form Type | 8-K |
| Filed Date | Mar 7, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $50,000, $35,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-compensation
Related Tickers: TGEN
TL;DR
TGEN board shakeup and exec appointments filed. Watch for new strategy.
AI Summary
On March 1, 2024, TECOGEN INC. filed an 8-K report detailing changes in its board of directors and executive officers, including the election of new directors and the appointment of certain officers. The filing also addresses compensatory arrangements for these key individuals. The company is incorporated in Delaware and headquartered in Waltham, Massachusetts.
Why It Matters
Changes in a company's board and executive team can signal shifts in strategy, governance, or operational focus, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in leadership and executive compensation can introduce uncertainty and signal potential strategic shifts, warranting closer monitoring.
Key Players & Entities
- TECOGEN INC. (company) — Registrant
- March 1, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Waltham, Massachusetts (location) — Principal Executive Offices
- TGEN (ticker) — Stock Ticker
FAQ
What specific changes were made to TECOGEN INC.'s board of directors?
The filing indicates the election of directors and departure of certain officers, but specific names and details of the changes are not provided in this summary section of the 8-K.
Were there any new appointments to executive officer positions at TECOGEN INC.?
Yes, the filing states the appointment of certain officers as part of the reported events.
Does the filing provide details on the compensatory arrangements for the new officers or directors?
The filing mentions that compensatory arrangements of certain officers are addressed, but specific details are not included in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on March 1, 2024.
What is TECOGEN INC.'s principal executive office address?
The principal executive offices are located at 45 First Avenue, Waltham, Massachusetts, 02451.
Filing Stats: 442 words · 2 min read · ~1 pages · Grade level 13.3 · Accepted 2024-03-07 14:57:54
Key Financial Figures
- $50,000 — ls. The amounts of the bonuses would be $50,000 for the Company's CEO, and $35,000 for
- $35,000 — d be $50,000 for the Company's CEO, and $35,000 for each of the Company's Chief Operati
Filing Documents
- tgen-20240301.htm (8-K) — 22KB
- tgen-20240301_g1.jpg (GRAPHIC) — 7KB
- 0001537435-24-000018.txt ( ) — 148KB
- tgen-20240301.xsd (EX-101.SCH) — 2KB
- tgen-20240301_lab.xml (EX-101.LAB) — 19KB
- tgen-20240301_pre.xml (EX-101.PRE) — 11KB
- tgen-20240301_htm.xml (XML) — 2KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. TECOGEN INC. By: /s/ Abinand Rangesh March 7, 2024 Abinand Rangesh, Chief Executive Officer